Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
:WST
RESEARCH TOOLSreports
Total Valuation
West Pharmaceutical Services has a market cap or net worth of $18.95B. The enterprise value is $18.42B.
Market Cap$18.95B
Enterprise Value$18.42B
Share Statistics
West Pharmaceutical Services has 71,907,326 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding71,907,326
Owned by Insiders0.57%
Owned by Institutions1.91%
Financial Efficiency
West Pharmaceutical Services’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 14.94%.
Return on Equity (ROE)0.18
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)14.94%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee272.94K
Profits Per Employee46.48K
Employee Count10,600
Asset Turnover0.79
Inventory Turnover5.03
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio39.5
PS Ratio0.00
PB Ratio0.00
Price to Fair Value8.91
Price to FCF55.50
Price to Operating Cash Flow28.39
PEG Ratio8.43
Income Statement
In the last 12 months, West Pharmaceutical Services had revenue of 2.89B and earned 492.70M in profits. Earnings per share was 6.75.
Revenue2.89B
Gross Profit998.50M
Operating Income569.90M
Pretax Income600.20M
Net Income492.70M
EBITDA743.80M
Earnings Per Share (EPS)6.75
Cash Flow
In the last 12 months, operating cash flow was 190.40M and capital expenditures -114.10M, giving a free cash flow of 76.30M billion.
Operating Cash Flow190.40M
Free Cash Flow76.30M
Free Cash Flow per Share1.06
Dividends & Yields
West Pharmaceutical Services pays an annual dividend of $0.827, resulting in a dividend yield of 0.31%
Dividend Per Share$0.827
Dividend Yield0.31%
Payout Ratio11.92%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.79
52-Week Price Change-8.27%
50-Day Moving Average220.31
200-Day Moving Average263.84
Relative Strength Index (RSI)67.83
Average Volume (3m)741.05K
Important Dates
West Pharmaceutical Services upcoming earnings date is Oct 23, 2025, Before Open (Confirmed).
Last Earnings DateJul 24, 2025
Next Earnings DateOct 23, 2025
Ex-Dividend DateJul 30, 2025
Financial Position
West Pharmaceutical Services as a current ratio of 2.79, with Debt / Equity ratio of 0.00%
Current Ratio2.79
Quick Ratio2.11
Debt to Market Cap<0.01
Net Debt to EBITDA-0.24
Interest Coverage Ratio189.97
Taxes
In the past 12 months, West Pharmaceutical Services has paid 107.50M in taxes.
Income Tax107.50M
Effective Tax Rate0.18
Enterprise Valuation
West Pharmaceutical Services EV to EBITDA ratio is 31.91, with an EV/FCF ratio of 85.86.
EV to Sales8.20
EV to EBITDA31.91
EV to Free Cash Flow85.86
EV to Operating Cash Flow36.32
Balance Sheet
West Pharmaceutical Services has $509.70M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$509.70M billion.
Cash & Marketable Securities$509.70M
Total Debt$0.00
Net Cash-$509.70M
Net Cash Per Share-$7.09
Tangible Book Value Per Share$35.14
Margins
Gross margin is 35.27%, with operating margin of 19.70%, and net profit margin of 17.03%.
Gross Margin35.27%
Operating Margin19.70%
Pretax Margin20.75%
Net Profit Margin17.03%
EBITDA Margin25.71%
EBIT Margin20.34%
Analyst Forecast
The average price target for West Pharmaceutical Services is $308.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$308.75
Price Target Upside17.17% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast2.88%
EPS Growth Forecast-5.50%